LTRN

Conviction 53HealthcareScan · Thu, Jun 25, 2026

Bearish engulfing

LTRN$3.68-6.84%

ResistanceSupportVol 14Insider buy

Vol MA14 200.11K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Lantern Pharma Inc.PHARMACEUTICAL PREPARATIONSwww.lanternpharma.com ↗

Price3.68

Change-6.84%

Gap+1.01%

Rel volume0.49×

Avg volume212.19K

Avg $ vol797.94K

SMA 203.77

SMA 503.06

SMA 2003.22

Price vs 50+20.32%

Price vs 200+14.17%

MA stackmixed

50/200 cross—

Supertrendup · 2.89

RSI (14)53

MACD hist-0.05

MACD crossbear · 7d

Stoch %K / %D26 / 52

ADX (14)40

+DI / −DI20 / 12

RSI divergenceBearish

MACD divergenceBearish

ATR %+9.58%

ADR %10.32%

52w high5.32

52w low1.12

From 52w high-30.83%

Above 52w low+228.57%

New 52w highNo

SqueezeOn · 6d

Bollinger width16.61%

%B0.36

Donchian pos48.52%

Donchian high4.20

Donchian low3.19

AVWAP (52w high)2.46

vs AVWAP high+49.63%

AVWAP (52w low)2.00

vs AVWAP low+83.75%

OBV trendUp

Chaikin MF (20)-0.02

Today vs 20d0.49×

Avg vol (14d)200.11K

Avg vol (20d)212.19K

Avg $ vol (20d)797.94K

Market cap41.6M

RS 3m (vs SPY)+64.87%

RS 6m (vs SPY)+13.43%

RS line new highNo

Trend template4/8

Technical rank71.9

1 week-5.40%

1 month+8.88%

3 months+65.77%

6 months+2.22%

1 year+14.64%

YTD+18.33%

P/E-2.43

P/B12.07

P/S—

P/FCF-2.65

EPS-1.57

Div yield—

ROE-496.83%

ROA-237.01%

Debt/Eq—

Current1.87

EV/EBITDA-2.04

Gross margin—

Net margin—

Rev growth—

EPS growth17.62%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value36.68M

Revenue—

Net income-3.33M

Gross profit—

Free cash flow-15.68M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out11.3M

Employees16

ListedThu, Jun 11, 2020

Free float7.66M

Float %68.5%

Short interest1.48M

Days to cover5.8d

Short volume57.1%

Squeeze score75 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction53 / 100

Pattern quality—

Tech rank71.9 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBearish engulfing

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 17 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Broke out
Jun 1
1 scan
→
Setting up
Jun 2 – Jun 24
4 scans

Congress activity

Disclosed STOCK Act trades in LTRN

All disclosures →

No recent disclosed trades by Congress in LTRN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in LTRN · 4 buys

Insider	Side	Shares	Value	Traded	Filed
KEYSER D JEFFREY Director · Common stock purchase warrant (Right to Buy) · 2026-05-12	Buy	48.54K	$0	2026-05-12	2026-05-14
Schalop Lee Troy Director · Common stock purchase warrant (Right to Buy) · 2026-05-12	Buy	48.54K	$0	2026-05-12	2026-05-14
KEYSER D JEFFREY Director · Common stock, $0.001 par value · 2026-05-12	Buy	48.54K	$100K	2026-05-12	2026-05-14
Schalop Lee Troy Director · Common stock, $0.001 par value · 2026-05-12	Buy	48.54K	$100K	2026-05-12	2026-05-14

SEC filings

EDGAR filings in LTRN · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.